Literature DB >> 32121371

Reliability and Validity of the Short-Form 12 Item Version 2 (SF-12v2) Health-Related Quality of Life Survey and Disutilities Associated with Relevant Conditions in the U.S. Older Adult Population.

Chintal H Shah1, Joshua D Brown2.   

Abstract

This study aimed to validate the Short-Form 12-Item Survey-version 2 (SF-12v2) in an older (≥65 years old) US population as well as estimate disutilities associated with relevant conditions, using data from the Medical Expenditure Panel Survey longitudinal panel (2014-2015). The physical component summary (PCS) and mental component summary (MCS) scores were examined for reliability (internal consistency, test-retest), construct validity (convergent and discriminant, structural), and criterion validity (concurrent and predictive). The study sample consisted of 1040 older adults with a mean age of 74.09 years (standard deviation: 6.19) PCS and MCS demonstrated high internal consistency (Cronbach's alpha-PCS: 0.87, MCS: 0.86) and good and moderate test-retest validity, respectively (intraclass correlation coefficient: PCS:0.79, MCS:0.59)). The questionnaire demonstrated sufficient convergent and discriminant ability. Confirmatory factor analysis showed adequate fit with the theoretical model and structural validity (goodness of fit = 0.9588). Concurrent criterion validity and predictive criterion validity were demonstrated. Activity limitations, functional limitations, arthritis, coronary heart disease, diabetes, myocardial infarction, stroke, angina, and high blood pressure were associated with disutilities of 0.18, 0.15, 0.06, 0.07, 0.07, 0.06, 0.09, 0.06, and 0.08, respectively, and demonstrated the responsiveness of the instrument to these conditions. The SF-12v2 is a valid and reliable instrument in an older US population.

Entities:  

Keywords:  Medial Expenditure Panel Survey; SF−12v2; disutility; health-related quality of life; older adults; psychometric properties; quality of life; reliability; utility; validity

Year:  2020        PMID: 32121371     DOI: 10.3390/jcm9030661

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  7 in total

1.  Plant-based dietary intake moderates adverse childhood experiences association with early mortality in an older Adventist cohort.

Authors:  Kelly R Morton; Jerry W Lee; Rhonda Spencer-Hwang
Journal:  J Psychosom Res       Date:  2021-09-28       Impact factor: 3.006

2.  Physical and mental health quality of life among underserved African American and Latino older adults.

Authors:  Mohsen Bazargan; Sharon Cobb; Shervin Assari; Shahrzad Bazargan-Hejazi
Journal:  Ethn Health       Date:  2022-01-30       Impact factor: 2.732

3.  Resourcefulness Intervention Efficacy for Parent Caregivers of Technology-Dependent Children: A Randomized Trial.

Authors:  Valerie Boebel Toly; Jaclene A Zauszniewski; Jiao Yu; Abdus Sattar; Bethany Rusincovitch; Carol M Musil
Journal:  West J Nurs Res       Date:  2021-12-29       Impact factor: 1.774

4.  Malnutrition Risk: Four Year Outcomes from the Health, Work and Retirement Study 2014 to 2018.

Authors:  Carol Wham; Jade Curnow; Andy Towers
Journal:  Nutrients       Date:  2022-05-26       Impact factor: 6.706

Review 5.  Reporting Survey Based Studies - a Primer for Authors.

Authors:  Prithvi Sanjeevkumar Gaur; Olena Zimba; Vikas Agarwal; Latika Gupta
Journal:  J Korean Med Sci       Date:  2020-11-23       Impact factor: 2.153

6.  Exploring the burden of short-term CHOP chemotherapy adverse events in post-transplant lymphoproliferative disease: a comprehensive literature review in lymphoma patients.

Authors:  Crystal Watson; Arie Barlev; Jodie Worrall; Steve Duff; Rachel Beckerman
Journal:  J Drug Assess       Date:  2020-12-24

Review 7.  The half-painted picture: Reviewing the mental health impacts of cancer screening.

Authors:  Lauren P Wadsworth; Inga Wessman; Andri Steinþór Björnsson; Gudbjorg Jonsdottir; Sigurður Yngvi Kristinsson
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.